Looking to publish in Acta Pharmaceutica Sinica B? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowActa Pharmaceutica Sinica B is a monthly English-language peer-reviewed journal that publishes significant original research articles, rapid communications, and high quality reviews across pharmaceutical sciences, including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, and pharmacokinetics. It is the journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association, and is produced and hosted by Elsevier B.V.
Looking to publish in Acta Pharmaceutica Sinica B? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Acta Pharmaceutica Sinica B accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review Article
Review Paper
Rapid Communications
Recent Publications
Target degradation of CASPASE-1 for alleviation of inflammation in sepsis via optogenetically engineered extracellular vesicles
Yuting Du, Dan Xiao, Heng Li, Li Fan, Kuo Shen, Bin Zhang, Liang Zhang, Lifei Guo, Qingzhe Li, Jinwang Zheng, Jingxiang Wang, Li Yao, Guodong Yang, Xuekang Yang
A dual-adjuvant nanovaccine drives lymph node macrophages reprogramming for robust cellular immunity
Jing-Yang Zhang, Kaishuo Wang, Rong Liu, Wei Xu, Wenchuan Xie, Yang Chen, Rongyuan Yang, Wei Zhang, Jin-Zhi Du
Metal-drug coordinated nanozymes for ROS scavenging and Kupffer cell polarization to alleviate drug-induced liver injury
Xiayun Chen, Ziqi Liang, Lichong Lu, Zhouchuan Shao, Wenhui Tang, Yiqi Liu, Jianqiao Li, Baizhong Chen, Enping Lai, Guodong Zheng, Minyan Wei, Shiying Li
Bispericyclase guided discovery of nargenicin-type natural products
Dandan Zou, Wen Wang, Linjiao Zou, Zhangyuan Yan, Ao Zhu, Zhikai Guo, Renxiang Tan, Bo Zhang, Huiming Ge
nCDR-binding peptide-based affinity recognition system stimulates the spatiotemporal fate study of biopharmaceuticals
Jingwei Zhou, Zhenhu liu, Peijun Ye, Ji Wu, Minyi Li, Jacques Crommen, Zhengjin Jiang, Qiqin Wang
Frequently asked questions
How long does it take to publish?
6 days from submission to first decision; 38 days from submission to decision after review; 210 days from submission to acceptance; 5 days from acceptance to online publication.
Reformat to Acta Pharmaceutica Sinica B using Livewrite PremiumWhat are the publication costs?
Article Publishing Charge: USD 2600 for Full Length Articles and Reviews; USD 2000 for Short Articles, excluding taxes.
Reformat to Acta Pharmaceutica Sinica B using Livewrite Premium